nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorouracil—ABCG2—epilepsy syndrome	0.149	0.696	CbGaD
Fluorouracil—ALB—epilepsy syndrome	0.0651	0.304	CbGaD
Fluorouracil—ABCC3—Phenobarbital—epilepsy syndrome	0.0384	0.0886	CbGbCtD
Fluorouracil—CYP2A6—Amobarbital—epilepsy syndrome	0.0239	0.0552	CbGbCtD
Fluorouracil—SLC22A7—Valproic Acid—epilepsy syndrome	0.0225	0.0518	CbGbCtD
Fluorouracil—ALB—Oxcarbazepine—epilepsy syndrome	0.0217	0.05	CbGbCtD
Fluorouracil—ALB—Fosphenytoin—epilepsy syndrome	0.0189	0.0437	CbGbCtD
Fluorouracil—CYP2A6—Propofol—epilepsy syndrome	0.0178	0.0412	CbGbCtD
Fluorouracil—ALB—Clonazepam—epilepsy syndrome	0.0171	0.0395	CbGbCtD
Fluorouracil—CYP2A6—Phenobarbital—epilepsy syndrome	0.0171	0.0394	CbGbCtD
Fluorouracil—CYP2C8—Trimethadione—epilepsy syndrome	0.0156	0.0359	CbGbCtD
Fluorouracil—CYP2C8—Fosphenytoin—epilepsy syndrome	0.0146	0.0338	CbGbCtD
Fluorouracil—ALB—Rufinamide—epilepsy syndrome	0.014	0.0322	CbGbCtD
Fluorouracil—CYP2A6—Valproic Acid—epilepsy syndrome	0.0127	0.0294	CbGbCtD
Fluorouracil—ALB—Phenytoin—epilepsy syndrome	0.0122	0.0282	CbGbCtD
Fluorouracil—ALB—Propofol—epilepsy syndrome	0.0114	0.0263	CbGbCtD
Fluorouracil—CYP2C9—Trimethadione—epilepsy syndrome	0.0109	0.0251	CbGbCtD
Fluorouracil—CYP2C8—Carbamazepine—epilepsy syndrome	0.0105	0.0243	CbGbCtD
Fluorouracil—ALB—Diazepam—epilepsy syndrome	0.0103	0.0238	CbGbCtD
Fluorouracil—CYP2C9—Fosphenytoin—epilepsy syndrome	0.0102	0.0236	CbGbCtD
Fluorouracil—CYP2C8—Primidone—epilepsy syndrome	0.00982	0.0227	CbGbCtD
Fluorouracil—CYP2C8—Phenytoin—epilepsy syndrome	0.00943	0.0218	CbGbCtD
Fluorouracil—CYP2C8—Propofol—epilepsy syndrome	0.0088	0.0203	CbGbCtD
Fluorouracil—CYP2C8—Phenobarbital—epilepsy syndrome	0.00841	0.0194	CbGbCtD
Fluorouracil—CYP1A2—Carbamazepine—epilepsy syndrome	0.00814	0.0188	CbGbCtD
Fluorouracil—CYP2C8—Diazepam—epilepsy syndrome	0.00797	0.0184	CbGbCtD
Fluorouracil—CYP1A2—Primidone—epilepsy syndrome	0.0076	0.0175	CbGbCtD
Fluorouracil—CYP2C9—Carbamazepine—epilepsy syndrome	0.00734	0.0169	CbGbCtD
Fluorouracil—CYP2C9—Primidone—epilepsy syndrome	0.00685	0.0158	CbGbCtD
Fluorouracil—CYP1A2—Propofol—epilepsy syndrome	0.00681	0.0157	CbGbCtD
Fluorouracil—CYP2C9—Phenytoin—epilepsy syndrome	0.00658	0.0152	CbGbCtD
Fluorouracil—CYP1A2—Phenobarbital—epilepsy syndrome	0.00651	0.015	CbGbCtD
Fluorouracil—CYP2C8—Valproic Acid—epilepsy syndrome	0.00628	0.0145	CbGbCtD
Fluorouracil—CYP1A2—Diazepam—epilepsy syndrome	0.00617	0.0142	CbGbCtD
Fluorouracil—CYP2C9—Propofol—epilepsy syndrome	0.00614	0.0142	CbGbCtD
Fluorouracil—CYP2C9—Phenobarbital—epilepsy syndrome	0.00587	0.0135	CbGbCtD
Fluorouracil—CYP2C9—Diazepam—epilepsy syndrome	0.00556	0.0128	CbGbCtD
Fluorouracil—CYP1A2—Valproic Acid—epilepsy syndrome	0.00486	0.0112	CbGbCtD
Fluorouracil—CYP2C9—Valproic Acid—epilepsy syndrome	0.00438	0.0101	CbGbCtD
Fluorouracil—UPP2—head—epilepsy syndrome	0.00172	0.04	CbGeAlD
Fluorouracil—MTHFR—ganglion—epilepsy syndrome	0.00165	0.0383	CbGeAlD
Fluorouracil—UPP2—nervous system—epilepsy syndrome	0.00163	0.0379	CbGeAlD
Fluorouracil—UPP2—central nervous system—epilepsy syndrome	0.00157	0.0365	CbGeAlD
Fluorouracil—UPP2—brain—epilepsy syndrome	0.00125	0.029	CbGeAlD
Fluorouracil—UMPS—medulla oblongata—epilepsy syndrome	0.00123	0.0286	CbGeAlD
Fluorouracil—UPP1—medulla oblongata—epilepsy syndrome	0.00113	0.0263	CbGeAlD
Fluorouracil—UMPS—midbrain—epilepsy syndrome	0.00112	0.0262	CbGeAlD
Fluorouracil—UPP1—midbrain—epilepsy syndrome	0.00103	0.024	CbGeAlD
Fluorouracil—UPP1—spinal cord—epilepsy syndrome	0.00101	0.0234	CbGeAlD
Fluorouracil—UMPS—head—epilepsy syndrome	0.000975	0.0227	CbGeAlD
Fluorouracil—UMPS—nervous system—epilepsy syndrome	0.000924	0.0215	CbGeAlD
Fluorouracil—UMPS—central nervous system—epilepsy syndrome	0.00089	0.0207	CbGeAlD
Fluorouracil—UMPS—cerebellum—epilepsy syndrome	0.00087	0.0202	CbGeAlD
Fluorouracil—UPP1—cerebellum—epilepsy syndrome	0.000797	0.0186	CbGeAlD
Fluorouracil—PPAT—medulla oblongata—epilepsy syndrome	0.000793	0.0185	CbGeAlD
Fluorouracil—TYMS—L-Glutamine—Vigabatrin—epilepsy syndrome	0.000791	0.329	CbGdCrCtD
Fluorouracil—PPAT—midbrain—epilepsy syndrome	0.000724	0.0169	CbGeAlD
Fluorouracil—PPAT—spinal cord—epilepsy syndrome	0.000707	0.0165	CbGeAlD
Fluorouracil—UMPS—brain—epilepsy syndrome	0.000706	0.0164	CbGeAlD
Fluorouracil—MTHFR—forebrain—epilepsy syndrome	0.00069	0.0161	CbGeAlD
Fluorouracil—UPP1—brain—epilepsy syndrome	0.000648	0.0151	CbGeAlD
Fluorouracil—MTHFR—telencephalon—epilepsy syndrome	0.000635	0.0148	CbGeAlD
Fluorouracil—PPAT—head—epilepsy syndrome	0.000628	0.0146	CbGeAlD
Fluorouracil—PPAT—nervous system—epilepsy syndrome	0.000596	0.0139	CbGeAlD
Fluorouracil—TYMS—telencephalon—epilepsy syndrome	0.000579	0.0135	CbGeAlD
Fluorouracil—PPAT—central nervous system—epilepsy syndrome	0.000573	0.0133	CbGeAlD
Fluorouracil—ABCC5—telencephalon—epilepsy syndrome	0.000566	0.0132	CbGeAlD
Fluorouracil—SLC29A1—forebrain—epilepsy syndrome	0.000565	0.0132	CbGeAlD
Fluorouracil—PPAT—cerebellum—epilepsy syndrome	0.00056	0.013	CbGeAlD
Fluorouracil—TYMP—medulla oblongata—epilepsy syndrome	0.000531	0.0124	CbGeAlD
Fluorouracil—DPYD—brain—epilepsy syndrome	0.000526	0.0122	CbGeAlD
Fluorouracil—SLC29A1—telencephalon—epilepsy syndrome	0.00052	0.0121	CbGeAlD
Fluorouracil—TYMP—midbrain—epilepsy syndrome	0.000485	0.0113	CbGeAlD
Fluorouracil—TYMP—spinal cord—epilepsy syndrome	0.000473	0.011	CbGeAlD
Fluorouracil—UMPS—Niclosamide—Clonazepam—epilepsy syndrome	0.000459	0.191	CbGdCrCtD
Fluorouracil—PPAT—brain—epilepsy syndrome	0.000455	0.0106	CbGeAlD
Fluorouracil—ABCC5—medulla oblongata—epilepsy syndrome	0.000445	0.0104	CbGeAlD
Fluorouracil—ABCC4—forebrain—epilepsy syndrome	0.000427	0.00993	CbGeAlD
Fluorouracil—TYMP—head—epilepsy syndrome	0.00042	0.00979	CbGeAlD
Fluorouracil—TYMS—midbrain—epilepsy syndrome	0.000416	0.00969	CbGeAlD
Fluorouracil—ABCC5—midbrain—epilepsy syndrome	0.000406	0.00946	CbGeAlD
Fluorouracil—TYMP—nervous system—epilepsy syndrome	0.000399	0.00928	CbGeAlD
Fluorouracil—MTHFR—head—epilepsy syndrome	0.000395	0.0092	CbGeAlD
Fluorouracil—UMPS—Chlorpromazine—Clobazam—epilepsy syndrome	0.000393	0.163	CbGdCrCtD
Fluorouracil—TYMP—central nervous system—epilepsy syndrome	0.000384	0.00894	CbGeAlD
Fluorouracil—TYMP—cerebellum—epilepsy syndrome	0.000375	0.00873	CbGeAlD
Fluorouracil—MTHFR—nervous system—epilepsy syndrome	0.000375	0.00873	CbGeAlD
Fluorouracil—MTHFR—central nervous system—epilepsy syndrome	0.000361	0.0084	CbGeAlD
Fluorouracil—TYMS—head—epilepsy syndrome	0.000361	0.0084	CbGeAlD
Fluorouracil—MTHFR—cerebellum—epilepsy syndrome	0.000353	0.00821	CbGeAlD
Fluorouracil—TYMS—nervous system—epilepsy syndrome	0.000342	0.00796	CbGeAlD
Fluorouracil—TYMS—central nervous system—epilepsy syndrome	0.000329	0.00767	CbGeAlD
Fluorouracil—SLC29A1—head—epilepsy syndrome	0.000324	0.00753	CbGeAlD
Fluorouracil—TYMS—cerebellum—epilepsy syndrome	0.000322	0.00749	CbGeAlD
Fluorouracil—ABCC5—cerebellum—epilepsy syndrome	0.000314	0.00732	CbGeAlD
Fluorouracil—SLC29A1—nervous system—epilepsy syndrome	0.000307	0.00714	CbGeAlD
Fluorouracil—TYMP—brain—epilepsy syndrome	0.000305	0.00709	CbGeAlD
Fluorouracil—SLC22A7—brain—epilepsy syndrome	0.000304	0.00707	CbGeAlD
Fluorouracil—ABCC3—head—epilepsy syndrome	0.000296	0.00689	CbGeAlD
Fluorouracil—SLC29A1—central nervous system—epilepsy syndrome	0.000295	0.00688	CbGeAlD
Fluorouracil—SLC29A1—cerebellum—epilepsy syndrome	0.000289	0.00672	CbGeAlD
Fluorouracil—MTHFR—brain—epilepsy syndrome	0.000286	0.00667	CbGeAlD
Fluorouracil—CYP2A6—cerebellum—epilepsy syndrome	0.000282	0.00656	CbGeAlD
Fluorouracil—ABCC3—nervous system—epilepsy syndrome	0.000281	0.00653	CbGeAlD
Fluorouracil—ABCG2—telencephalon—epilepsy syndrome	0.000277	0.00645	CbGeAlD
Fluorouracil—ABCC3—central nervous system—epilepsy syndrome	0.00027	0.00629	CbGeAlD
Fluorouracil—TYMS—brain—epilepsy syndrome	0.000261	0.00609	CbGeAlD
Fluorouracil—ABCC5—brain—epilepsy syndrome	0.000255	0.00595	CbGeAlD
Fluorouracil—ABCC4—head—epilepsy syndrome	0.000244	0.00569	CbGeAlD
Fluorouracil—SLC29A1—brain—epilepsy syndrome	0.000234	0.00546	CbGeAlD
Fluorouracil—ABCC4—nervous system—epilepsy syndrome	0.000232	0.00539	CbGeAlD
Fluorouracil—CYP2A6—brain—epilepsy syndrome	0.000229	0.00533	CbGeAlD
Fluorouracil—ABCC4—central nervous system—epilepsy syndrome	0.000223	0.00519	CbGeAlD
Fluorouracil—ABCG2—medulla oblongata—epilepsy syndrome	0.000218	0.00507	CbGeAlD
Fluorouracil—ABCC3—brain—epilepsy syndrome	0.000214	0.00499	CbGeAlD
Fluorouracil—ABCG2—midbrain—epilepsy syndrome	0.000199	0.00463	CbGeAlD
Fluorouracil—ABCG2—spinal cord—epilepsy syndrome	0.000194	0.00452	CbGeAlD
Fluorouracil—ALB—brain—epilepsy syndrome	0.000183	0.00426	CbGeAlD
Fluorouracil—ABCC4—brain—epilepsy syndrome	0.000177	0.00412	CbGeAlD
Fluorouracil—TYMS—Bortezomib—Lacosamide—epilepsy syndrome	0.000166	0.0688	CbGdCrCtD
Fluorouracil—ABCG2—cerebellum—epilepsy syndrome	0.000154	0.00358	CbGeAlD
Fluorouracil—TYMS—Nortriptyline—Oxcarbazepine—epilepsy syndrome	0.000152	0.0632	CbGdCrCtD
Fluorouracil—CYP2C8—brain—epilepsy syndrome	0.000129	0.00299	CbGeAlD
Fluorouracil—ABCG2—brain—epilepsy syndrome	0.000125	0.00291	CbGeAlD
Fluorouracil—TYMS—Chlorprothixene—Midazolam—epilepsy syndrome	0.000123	0.0511	CbGdCrCtD
Fluorouracil—TYMS—Niclosamide—Clonazepam—epilepsy syndrome	0.000115	0.0477	CbGdCrCtD
Fluorouracil—TYMS—Chlorprothixene—Diazepam—epilepsy syndrome	0.00011	0.0455	CbGdCrCtD
Fluorouracil—TYMS—Chlorpromazine—Clobazam—epilepsy syndrome	9.83e-05	0.0409	CbGdCrCtD
Fluorouracil—Diarrhoea—Vigabatrin—epilepsy syndrome	5.24e-05	0.000293	CcSEcCtD
Fluorouracil—Vision blurred—Pregabalin—epilepsy syndrome	5.23e-05	0.000293	CcSEcCtD
Fluorouracil—Chest pain—Valproic Acid—epilepsy syndrome	5.23e-05	0.000293	CcSEcCtD
Fluorouracil—Myalgia—Valproic Acid—epilepsy syndrome	5.23e-05	0.000293	CcSEcCtD
Fluorouracil—Feeling abnormal—Lamotrigine—epilepsy syndrome	5.2e-05	0.000291	CcSEcCtD
Fluorouracil—Rash—Midazolam—epilepsy syndrome	5.2e-05	0.000291	CcSEcCtD
Fluorouracil—Dizziness—Fosphenytoin—epilepsy syndrome	5.19e-05	0.000291	CcSEcCtD
Fluorouracil—Dermatitis—Midazolam—epilepsy syndrome	5.19e-05	0.00029	CcSEcCtD
Fluorouracil—Urticaria—Carbamazepine—epilepsy syndrome	5.18e-05	0.00029	CcSEcCtD
Fluorouracil—Vomiting—Levetiracetam—epilepsy syndrome	5.17e-05	0.00029	CcSEcCtD
Fluorouracil—Epistaxis—Topiramate—epilepsy syndrome	5.17e-05	0.000289	CcSEcCtD
Fluorouracil—Alopecia—Gabapentin—epilepsy syndrome	5.17e-05	0.000289	CcSEcCtD
Fluorouracil—Discomfort—Valproic Acid—epilepsy syndrome	5.16e-05	0.000289	CcSEcCtD
Fluorouracil—Headache—Midazolam—epilepsy syndrome	5.16e-05	0.000289	CcSEcCtD
Fluorouracil—Pruritus—Felbamate—epilepsy syndrome	5.16e-05	0.000289	CcSEcCtD
Fluorouracil—Body temperature increased—Carbamazepine—epilepsy syndrome	5.16e-05	0.000289	CcSEcCtD
Fluorouracil—Diarrhoea—Diazepam—epilepsy syndrome	5.16e-05	0.000289	CcSEcCtD
Fluorouracil—Sinusitis—Topiramate—epilepsy syndrome	5.14e-05	0.000288	CcSEcCtD
Fluorouracil—Rash—Levetiracetam—epilepsy syndrome	5.13e-05	0.000287	CcSEcCtD
Fluorouracil—Anaemia—Pregabalin—epilepsy syndrome	5.13e-05	0.000287	CcSEcCtD
Fluorouracil—Dermatitis—Levetiracetam—epilepsy syndrome	5.13e-05	0.000287	CcSEcCtD
Fluorouracil—Agranulocytosis—Topiramate—epilepsy syndrome	5.11e-05	0.000286	CcSEcCtD
Fluorouracil—Headache—Levetiracetam—epilepsy syndrome	5.1e-05	0.000285	CcSEcCtD
Fluorouracil—Erythema—Gabapentin—epilepsy syndrome	5.09e-05	0.000285	CcSEcCtD
Fluorouracil—Hypersensitivity—Clonazepam—epilepsy syndrome	5.07e-05	0.000284	CcSEcCtD
Fluorouracil—Dizziness—Vigabatrin—epilepsy syndrome	5.06e-05	0.000283	CcSEcCtD
Fluorouracil—Confusional state—Valproic Acid—epilepsy syndrome	5.05e-05	0.000283	CcSEcCtD
Fluorouracil—Pruritus—Zonisamide—epilepsy syndrome	5.05e-05	0.000283	CcSEcCtD
Fluorouracil—Hypersensitivity—Phenytoin—epilepsy syndrome	5.04e-05	0.000282	CcSEcCtD
Fluorouracil—Oedema—Valproic Acid—epilepsy syndrome	5.01e-05	0.00028	CcSEcCtD
Fluorouracil—Anaphylactic shock—Valproic Acid—epilepsy syndrome	5.01e-05	0.00028	CcSEcCtD
Fluorouracil—Urticaria—Lamotrigine—epilepsy syndrome	5.01e-05	0.00028	CcSEcCtD
Fluorouracil—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	5.01e-05	0.00028	CcSEcCtD
Fluorouracil—Nausea—Propofol—epilepsy syndrome	5e-05	0.00028	CcSEcCtD
Fluorouracil—Vomiting—Fosphenytoin—epilepsy syndrome	4.99e-05	0.000279	CcSEcCtD
Fluorouracil—Diarrhoea—Felbamate—epilepsy syndrome	4.99e-05	0.000279	CcSEcCtD
Fluorouracil—Body temperature increased—Lamotrigine—epilepsy syndrome	4.98e-05	0.000279	CcSEcCtD
Fluorouracil—Dizziness—Diazepam—epilepsy syndrome	4.98e-05	0.000279	CcSEcCtD
Fluorouracil—Infection—Valproic Acid—epilepsy syndrome	4.98e-05	0.000279	CcSEcCtD
Fluorouracil—Leukopenia—Pregabalin—epilepsy syndrome	4.97e-05	0.000278	CcSEcCtD
Fluorouracil—Rash—Fosphenytoin—epilepsy syndrome	4.95e-05	0.000277	CcSEcCtD
Fluorouracil—Dermatitis—Fosphenytoin—epilepsy syndrome	4.95e-05	0.000277	CcSEcCtD
Fluorouracil—Haemoglobin—Topiramate—epilepsy syndrome	4.94e-05	0.000277	CcSEcCtD
Fluorouracil—Rhinitis—Topiramate—epilepsy syndrome	4.93e-05	0.000276	CcSEcCtD
Fluorouracil—Headache—Fosphenytoin—epilepsy syndrome	4.92e-05	0.000275	CcSEcCtD
Fluorouracil—Haemorrhage—Topiramate—epilepsy syndrome	4.92e-05	0.000275	CcSEcCtD
Fluorouracil—Nervous system disorder—Valproic Acid—epilepsy syndrome	4.91e-05	0.000275	CcSEcCtD
Fluorouracil—Thrombocytopenia—Valproic Acid—epilepsy syndrome	4.91e-05	0.000275	CcSEcCtD
Fluorouracil—Nausea—Midazolam—epilepsy syndrome	4.89e-05	0.000274	CcSEcCtD
Fluorouracil—Hypoaesthesia—Topiramate—epilepsy syndrome	4.89e-05	0.000274	CcSEcCtD
Fluorouracil—Tachycardia—Valproic Acid—epilepsy syndrome	4.89e-05	0.000274	CcSEcCtD
Fluorouracil—Diarrhoea—Zonisamide—epilepsy syndrome	4.89e-05	0.000273	CcSEcCtD
Fluorouracil—Pharyngitis—Topiramate—epilepsy syndrome	4.88e-05	0.000273	CcSEcCtD
Fluorouracil—Pruritus—Clonazepam—epilepsy syndrome	4.87e-05	0.000272	CcSEcCtD
Fluorouracil—Vomiting—Vigabatrin—epilepsy syndrome	4.87e-05	0.000272	CcSEcCtD
Fluorouracil—Pruritus—Phenytoin—epilepsy syndrome	4.84e-05	0.000271	CcSEcCtD
Fluorouracil—Nausea—Levetiracetam—epilepsy syndrome	4.83e-05	0.00027	CcSEcCtD
Fluorouracil—Rash—Vigabatrin—epilepsy syndrome	4.83e-05	0.00027	CcSEcCtD
Fluorouracil—Dizziness—Felbamate—epilepsy syndrome	4.82e-05	0.00027	CcSEcCtD
Fluorouracil—Dermatitis—Vigabatrin—epilepsy syndrome	4.82e-05	0.00027	CcSEcCtD
Fluorouracil—Pruritus—Oxcarbazepine—epilepsy syndrome	4.81e-05	0.000269	CcSEcCtD
Fluorouracil—Convulsion—Pregabalin—epilepsy syndrome	4.81e-05	0.000269	CcSEcCtD
Fluorouracil—Hypersensitivity—Carbamazepine—epilepsy syndrome	4.81e-05	0.000269	CcSEcCtD
Fluorouracil—Vision blurred—Gabapentin—epilepsy syndrome	4.8e-05	0.000268	CcSEcCtD
Fluorouracil—Headache—Vigabatrin—epilepsy syndrome	4.8e-05	0.000268	CcSEcCtD
Fluorouracil—Vomiting—Diazepam—epilepsy syndrome	4.79e-05	0.000268	CcSEcCtD
Fluorouracil—Anorexia—Valproic Acid—epilepsy syndrome	4.78e-05	0.000267	CcSEcCtD
Fluorouracil—Rash—Diazepam—epilepsy syndrome	4.75e-05	0.000266	CcSEcCtD
Fluorouracil—Dermatitis—Diazepam—epilepsy syndrome	4.75e-05	0.000266	CcSEcCtD
Fluorouracil—Myalgia—Pregabalin—epilepsy syndrome	4.73e-05	0.000264	CcSEcCtD
Fluorouracil—Chest pain—Pregabalin—epilepsy syndrome	4.73e-05	0.000264	CcSEcCtD
Fluorouracil—Dizziness—Zonisamide—epilepsy syndrome	4.72e-05	0.000264	CcSEcCtD
Fluorouracil—Headache—Diazepam—epilepsy syndrome	4.72e-05	0.000264	CcSEcCtD
Fluorouracil—Diarrhoea—Clonazepam—epilepsy syndrome	4.71e-05	0.000263	CcSEcCtD
Fluorouracil—Anaemia—Gabapentin—epilepsy syndrome	4.7e-05	0.000263	CcSEcCtD
Fluorouracil—Hypotension—Valproic Acid—epilepsy syndrome	4.68e-05	0.000262	CcSEcCtD
Fluorouracil—Diarrhoea—Phenytoin—epilepsy syndrome	4.68e-05	0.000262	CcSEcCtD
Fluorouracil—Discomfort—Pregabalin—epilepsy syndrome	4.67e-05	0.000261	CcSEcCtD
Fluorouracil—Nausea—Fosphenytoin—epilepsy syndrome	4.66e-05	0.000261	CcSEcCtD
Fluorouracil—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.65e-05	0.00026	CcSEcCtD
Fluorouracil—Hypersensitivity—Lamotrigine—epilepsy syndrome	4.65e-05	0.00026	CcSEcCtD
Fluorouracil—Vomiting—Felbamate—epilepsy syndrome	4.64e-05	0.00026	CcSEcCtD
Fluorouracil—Pruritus—Carbamazepine—epilepsy syndrome	4.62e-05	0.000258	CcSEcCtD
Fluorouracil—Rash—Felbamate—epilepsy syndrome	4.6e-05	0.000257	CcSEcCtD
Fluorouracil—Dermatitis—Felbamate—epilepsy syndrome	4.59e-05	0.000257	CcSEcCtD
Fluorouracil—Headache—Felbamate—epilepsy syndrome	4.57e-05	0.000256	CcSEcCtD
Fluorouracil—Confusional state—Pregabalin—epilepsy syndrome	4.57e-05	0.000256	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	4.57e-05	0.000255	CcSEcCtD
Fluorouracil—Leukopenia—Gabapentin—epilepsy syndrome	4.56e-05	0.000255	CcSEcCtD
Fluorouracil—Dizziness—Clonazepam—epilepsy syndrome	4.55e-05	0.000255	CcSEcCtD
Fluorouracil—Nausea—Vigabatrin—epilepsy syndrome	4.55e-05	0.000254	CcSEcCtD
Fluorouracil—Vomiting—Zonisamide—epilepsy syndrome	4.54e-05	0.000254	CcSEcCtD
Fluorouracil—Insomnia—Valproic Acid—epilepsy syndrome	4.53e-05	0.000254	CcSEcCtD
Fluorouracil—Anaphylactic shock—Pregabalin—epilepsy syndrome	4.53e-05	0.000254	CcSEcCtD
Fluorouracil—Oedema—Pregabalin—epilepsy syndrome	4.53e-05	0.000254	CcSEcCtD
Fluorouracil—Dizziness—Phenytoin—epilepsy syndrome	4.52e-05	0.000253	CcSEcCtD
Fluorouracil—Rash—Zonisamide—epilepsy syndrome	4.5e-05	0.000252	CcSEcCtD
Fluorouracil—Infection—Pregabalin—epilepsy syndrome	4.5e-05	0.000252	CcSEcCtD
Fluorouracil—Paraesthesia—Valproic Acid—epilepsy syndrome	4.5e-05	0.000252	CcSEcCtD
Fluorouracil—Dermatitis—Zonisamide—epilepsy syndrome	4.5e-05	0.000252	CcSEcCtD
Fluorouracil—Dizziness—Oxcarbazepine—epilepsy syndrome	4.5e-05	0.000252	CcSEcCtD
Fluorouracil—Nausea—Diazepam—epilepsy syndrome	4.48e-05	0.000251	CcSEcCtD
Fluorouracil—Headache—Zonisamide—epilepsy syndrome	4.47e-05	0.00025	CcSEcCtD
Fluorouracil—Dyspnoea—Valproic Acid—epilepsy syndrome	4.47e-05	0.00025	CcSEcCtD
Fluorouracil—Diarrhoea—Carbamazepine—epilepsy syndrome	4.46e-05	0.00025	CcSEcCtD
Fluorouracil—Pruritus—Lamotrigine—epilepsy syndrome	4.46e-05	0.00025	CcSEcCtD
Fluorouracil—Somnolence—Valproic Acid—epilepsy syndrome	4.45e-05	0.000249	CcSEcCtD
Fluorouracil—Nervous system disorder—Pregabalin—epilepsy syndrome	4.44e-05	0.000249	CcSEcCtD
Fluorouracil—Thrombocytopenia—Pregabalin—epilepsy syndrome	4.44e-05	0.000248	CcSEcCtD
Fluorouracil—Tachycardia—Pregabalin—epilepsy syndrome	4.42e-05	0.000247	CcSEcCtD
Fluorouracil—Dyspepsia—Valproic Acid—epilepsy syndrome	4.41e-05	0.000247	CcSEcCtD
Fluorouracil—Convulsion—Gabapentin—epilepsy syndrome	4.41e-05	0.000247	CcSEcCtD
Fluorouracil—Vomiting—Clonazepam—epilepsy syndrome	4.38e-05	0.000245	CcSEcCtD
Fluorouracil—Decreased appetite—Valproic Acid—epilepsy syndrome	4.36e-05	0.000244	CcSEcCtD
Fluorouracil—Alopecia—Topiramate—epilepsy syndrome	4.35e-05	0.000243	CcSEcCtD
Fluorouracil—Vomiting—Phenytoin—epilepsy syndrome	4.35e-05	0.000243	CcSEcCtD
Fluorouracil—Rash—Clonazepam—epilepsy syndrome	4.34e-05	0.000243	CcSEcCtD
Fluorouracil—Dermatitis—Clonazepam—epilepsy syndrome	4.33e-05	0.000243	CcSEcCtD
Fluorouracil—Chest pain—Gabapentin—epilepsy syndrome	4.33e-05	0.000242	CcSEcCtD
Fluorouracil—Myalgia—Gabapentin—epilepsy syndrome	4.33e-05	0.000242	CcSEcCtD
Fluorouracil—Nausea—Felbamate—epilepsy syndrome	4.33e-05	0.000242	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	4.33e-05	0.000242	CcSEcCtD
Fluorouracil—Vomiting—Oxcarbazepine—epilepsy syndrome	4.32e-05	0.000242	CcSEcCtD
Fluorouracil—Anorexia—Pregabalin—epilepsy syndrome	4.32e-05	0.000242	CcSEcCtD
Fluorouracil—Dizziness—Carbamazepine—epilepsy syndrome	4.31e-05	0.000241	CcSEcCtD
Fluorouracil—Diarrhoea—Lamotrigine—epilepsy syndrome	4.31e-05	0.000241	CcSEcCtD
Fluorouracil—Headache—Clonazepam—epilepsy syndrome	4.31e-05	0.000241	CcSEcCtD
Fluorouracil—Rash—Phenytoin—epilepsy syndrome	4.31e-05	0.000241	CcSEcCtD
Fluorouracil—Dermatitis—Phenytoin—epilepsy syndrome	4.31e-05	0.000241	CcSEcCtD
Fluorouracil—Rash—Oxcarbazepine—epilepsy syndrome	4.29e-05	0.00024	CcSEcCtD
Fluorouracil—Pain—Valproic Acid—epilepsy syndrome	4.28e-05	0.00024	CcSEcCtD
Fluorouracil—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.28e-05	0.00024	CcSEcCtD
Fluorouracil—Headache—Phenytoin—epilepsy syndrome	4.28e-05	0.00024	CcSEcCtD
Fluorouracil—Erythema—Topiramate—epilepsy syndrome	4.28e-05	0.00024	CcSEcCtD
Fluorouracil—Discomfort—Gabapentin—epilepsy syndrome	4.28e-05	0.00024	CcSEcCtD
Fluorouracil—Headache—Oxcarbazepine—epilepsy syndrome	4.26e-05	0.000238	CcSEcCtD
Fluorouracil—Nausea—Zonisamide—epilepsy syndrome	4.24e-05	0.000237	CcSEcCtD
Fluorouracil—Hypotension—Pregabalin—epilepsy syndrome	4.23e-05	0.000237	CcSEcCtD
Fluorouracil—Confusional state—Gabapentin—epilepsy syndrome	4.19e-05	0.000234	CcSEcCtD
Fluorouracil—Dizziness—Lamotrigine—epilepsy syndrome	4.17e-05	0.000233	CcSEcCtD
Fluorouracil—Anaphylactic shock—Gabapentin—epilepsy syndrome	4.15e-05	0.000232	CcSEcCtD
Fluorouracil—Oedema—Gabapentin—epilepsy syndrome	4.15e-05	0.000232	CcSEcCtD
Fluorouracil—Vomiting—Carbamazepine—epilepsy syndrome	4.15e-05	0.000232	CcSEcCtD
Fluorouracil—Feeling abnormal—Valproic Acid—epilepsy syndrome	4.13e-05	0.000231	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	4.13e-05	0.000231	CcSEcCtD
Fluorouracil—Infection—Gabapentin—epilepsy syndrome	4.13e-05	0.000231	CcSEcCtD
Fluorouracil—Rash—Carbamazepine—epilepsy syndrome	4.11e-05	0.00023	CcSEcCtD
Fluorouracil—Dermatitis—Carbamazepine—epilepsy syndrome	4.11e-05	0.00023	CcSEcCtD
Fluorouracil—Insomnia—Pregabalin—epilepsy syndrome	4.1e-05	0.000229	CcSEcCtD
Fluorouracil—Nausea—Clonazepam—epilepsy syndrome	4.09e-05	0.000229	CcSEcCtD
Fluorouracil—Headache—Carbamazepine—epilepsy syndrome	4.09e-05	0.000229	CcSEcCtD
Fluorouracil—Nervous system disorder—Gabapentin—epilepsy syndrome	4.07e-05	0.000228	CcSEcCtD
Fluorouracil—Paraesthesia—Pregabalin—epilepsy syndrome	4.07e-05	0.000228	CcSEcCtD
Fluorouracil—Thrombocytopenia—Gabapentin—epilepsy syndrome	4.07e-05	0.000228	CcSEcCtD
Fluorouracil—Nausea—Phenytoin—epilepsy syndrome	4.06e-05	0.000227	CcSEcCtD
Fluorouracil—Tachycardia—Gabapentin—epilepsy syndrome	4.05e-05	0.000227	CcSEcCtD
Fluorouracil—Dyspnoea—Pregabalin—epilepsy syndrome	4.04e-05	0.000226	CcSEcCtD
Fluorouracil—Nausea—Oxcarbazepine—epilepsy syndrome	4.04e-05	0.000226	CcSEcCtD
Fluorouracil—Vision blurred—Topiramate—epilepsy syndrome	4.04e-05	0.000226	CcSEcCtD
Fluorouracil—Somnolence—Pregabalin—epilepsy syndrome	4.03e-05	0.000225	CcSEcCtD
Fluorouracil—Vomiting—Lamotrigine—epilepsy syndrome	4.01e-05	0.000224	CcSEcCtD
Fluorouracil—Urticaria—Valproic Acid—epilepsy syndrome	3.98e-05	0.000223	CcSEcCtD
Fluorouracil—Rash—Lamotrigine—epilepsy syndrome	3.98e-05	0.000223	CcSEcCtD
Fluorouracil—Dermatitis—Lamotrigine—epilepsy syndrome	3.97e-05	0.000222	CcSEcCtD
Fluorouracil—Body temperature increased—Valproic Acid—epilepsy syndrome	3.96e-05	0.000222	CcSEcCtD
Fluorouracil—Anorexia—Gabapentin—epilepsy syndrome	3.96e-05	0.000222	CcSEcCtD
Fluorouracil—Anaemia—Topiramate—epilepsy syndrome	3.96e-05	0.000221	CcSEcCtD
Fluorouracil—Headache—Lamotrigine—epilepsy syndrome	3.95e-05	0.000221	CcSEcCtD
Fluorouracil—Decreased appetite—Pregabalin—epilepsy syndrome	3.94e-05	0.00022	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	3.91e-05	0.000219	CcSEcCtD
Fluorouracil—Hypotension—Gabapentin—epilepsy syndrome	3.88e-05	0.000217	CcSEcCtD
Fluorouracil—Nausea—Carbamazepine—epilepsy syndrome	3.88e-05	0.000217	CcSEcCtD
Fluorouracil—Pain—Pregabalin—epilepsy syndrome	3.87e-05	0.000217	CcSEcCtD
Fluorouracil—Leukopenia—Topiramate—epilepsy syndrome	3.83e-05	0.000215	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.78e-05	0.000212	CcSEcCtD
Fluorouracil—Insomnia—Gabapentin—epilepsy syndrome	3.76e-05	0.00021	CcSEcCtD
Fluorouracil—Nausea—Lamotrigine—epilepsy syndrome	3.75e-05	0.00021	CcSEcCtD
Fluorouracil—Feeling abnormal—Pregabalin—epilepsy syndrome	3.73e-05	0.000209	CcSEcCtD
Fluorouracil—Paraesthesia—Gabapentin—epilepsy syndrome	3.73e-05	0.000209	CcSEcCtD
Fluorouracil—Convulsion—Topiramate—epilepsy syndrome	3.71e-05	0.000208	CcSEcCtD
Fluorouracil—Dyspnoea—Gabapentin—epilepsy syndrome	3.7e-05	0.000207	CcSEcCtD
Fluorouracil—Somnolence—Gabapentin—epilepsy syndrome	3.69e-05	0.000207	CcSEcCtD
Fluorouracil—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.69e-05	0.000207	CcSEcCtD
Fluorouracil—Dyspepsia—Gabapentin—epilepsy syndrome	3.66e-05	0.000205	CcSEcCtD
Fluorouracil—Chest pain—Topiramate—epilepsy syndrome	3.65e-05	0.000204	CcSEcCtD
Fluorouracil—Myalgia—Topiramate—epilepsy syndrome	3.65e-05	0.000204	CcSEcCtD
Fluorouracil—Decreased appetite—Gabapentin—epilepsy syndrome	3.61e-05	0.000202	CcSEcCtD
Fluorouracil—Discomfort—Topiramate—epilepsy syndrome	3.6e-05	0.000202	CcSEcCtD
Fluorouracil—Urticaria—Pregabalin—epilepsy syndrome	3.6e-05	0.000201	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	3.59e-05	0.000201	CcSEcCtD
Fluorouracil—Body temperature increased—Pregabalin—epilepsy syndrome	3.58e-05	0.0002	CcSEcCtD
Fluorouracil—Pain—Gabapentin—epilepsy syndrome	3.55e-05	0.000199	CcSEcCtD
Fluorouracil—Pruritus—Valproic Acid—epilepsy syndrome	3.54e-05	0.000198	CcSEcCtD
Fluorouracil—Confusional state—Topiramate—epilepsy syndrome	3.52e-05	0.000197	CcSEcCtD
Fluorouracil—Oedema—Topiramate—epilepsy syndrome	3.49e-05	0.000196	CcSEcCtD
Fluorouracil—Infection—Topiramate—epilepsy syndrome	3.47e-05	0.000194	CcSEcCtD
Fluorouracil—Diarrhoea—Valproic Acid—epilepsy syndrome	3.43e-05	0.000192	CcSEcCtD
Fluorouracil—Nervous system disorder—Topiramate—epilepsy syndrome	3.43e-05	0.000192	CcSEcCtD
Fluorouracil—Feeling abnormal—Gabapentin—epilepsy syndrome	3.42e-05	0.000192	CcSEcCtD
Fluorouracil—Thrombocytopenia—Topiramate—epilepsy syndrome	3.42e-05	0.000191	CcSEcCtD
Fluorouracil—Tachycardia—Topiramate—epilepsy syndrome	3.41e-05	0.000191	CcSEcCtD
Fluorouracil—Hypersensitivity—Pregabalin—epilepsy syndrome	3.34e-05	0.000187	CcSEcCtD
Fluorouracil—Anorexia—Topiramate—epilepsy syndrome	3.33e-05	0.000186	CcSEcCtD
Fluorouracil—Dizziness—Valproic Acid—epilepsy syndrome	3.31e-05	0.000185	CcSEcCtD
Fluorouracil—Urticaria—Gabapentin—epilepsy syndrome	3.3e-05	0.000185	CcSEcCtD
Fluorouracil—Body temperature increased—Gabapentin—epilepsy syndrome	3.28e-05	0.000184	CcSEcCtD
Fluorouracil—Hypotension—Topiramate—epilepsy syndrome	3.27e-05	0.000183	CcSEcCtD
Fluorouracil—Pruritus—Pregabalin—epilepsy syndrome	3.2e-05	0.000179	CcSEcCtD
Fluorouracil—Vomiting—Valproic Acid—epilepsy syndrome	3.19e-05	0.000178	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.18e-05	0.000178	CcSEcCtD
Fluorouracil—Insomnia—Topiramate—epilepsy syndrome	3.16e-05	0.000177	CcSEcCtD
Fluorouracil—Rash—Valproic Acid—epilepsy syndrome	3.16e-05	0.000177	CcSEcCtD
Fluorouracil—Dermatitis—Valproic Acid—epilepsy syndrome	3.16e-05	0.000177	CcSEcCtD
Fluorouracil—Headache—Valproic Acid—epilepsy syndrome	3.14e-05	0.000176	CcSEcCtD
Fluorouracil—Paraesthesia—Topiramate—epilepsy syndrome	3.14e-05	0.000176	CcSEcCtD
Fluorouracil—Dyspnoea—Topiramate—epilepsy syndrome	3.12e-05	0.000174	CcSEcCtD
Fluorouracil—Somnolence—Topiramate—epilepsy syndrome	3.11e-05	0.000174	CcSEcCtD
Fluorouracil—Diarrhoea—Pregabalin—epilepsy syndrome	3.1e-05	0.000173	CcSEcCtD
Fluorouracil—Dyspepsia—Topiramate—epilepsy syndrome	3.08e-05	0.000172	CcSEcCtD
Fluorouracil—Hypersensitivity—Gabapentin—epilepsy syndrome	3.06e-05	0.000171	CcSEcCtD
Fluorouracil—Decreased appetite—Topiramate—epilepsy syndrome	3.04e-05	0.00017	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3.02e-05	0.000169	CcSEcCtD
Fluorouracil—Dizziness—Pregabalin—epilepsy syndrome	3e-05	0.000168	CcSEcCtD
Fluorouracil—Pain—Topiramate—epilepsy syndrome	2.99e-05	0.000167	CcSEcCtD
Fluorouracil—Nausea—Valproic Acid—epilepsy syndrome	2.98e-05	0.000167	CcSEcCtD
Fluorouracil—Pruritus—Gabapentin—epilepsy syndrome	2.94e-05	0.000164	CcSEcCtD
Fluorouracil—Vomiting—Pregabalin—epilepsy syndrome	2.88e-05	0.000161	CcSEcCtD
Fluorouracil—Feeling abnormal—Topiramate—epilepsy syndrome	2.88e-05	0.000161	CcSEcCtD
Fluorouracil—Rash—Pregabalin—epilepsy syndrome	2.86e-05	0.00016	CcSEcCtD
Fluorouracil—Dermatitis—Pregabalin—epilepsy syndrome	2.85e-05	0.00016	CcSEcCtD
Fluorouracil—Diarrhoea—Gabapentin—epilepsy syndrome	2.84e-05	0.000159	CcSEcCtD
Fluorouracil—Headache—Pregabalin—epilepsy syndrome	2.84e-05	0.000159	CcSEcCtD
Fluorouracil—Urticaria—Topiramate—epilepsy syndrome	2.78e-05	0.000155	CcSEcCtD
Fluorouracil—Body temperature increased—Topiramate—epilepsy syndrome	2.76e-05	0.000155	CcSEcCtD
Fluorouracil—Dizziness—Gabapentin—epilepsy syndrome	2.75e-05	0.000154	CcSEcCtD
Fluorouracil—Nausea—Pregabalin—epilepsy syndrome	2.69e-05	0.000151	CcSEcCtD
Fluorouracil—Vomiting—Gabapentin—epilepsy syndrome	2.64e-05	0.000148	CcSEcCtD
Fluorouracil—Rash—Gabapentin—epilepsy syndrome	2.62e-05	0.000147	CcSEcCtD
Fluorouracil—Dermatitis—Gabapentin—epilepsy syndrome	2.62e-05	0.000146	CcSEcCtD
Fluorouracil—Headache—Gabapentin—epilepsy syndrome	2.6e-05	0.000146	CcSEcCtD
Fluorouracil—Hypersensitivity—Topiramate—epilepsy syndrome	2.57e-05	0.000144	CcSEcCtD
Fluorouracil—Pruritus—Topiramate—epilepsy syndrome	2.47e-05	0.000138	CcSEcCtD
Fluorouracil—Nausea—Gabapentin—epilepsy syndrome	2.47e-05	0.000138	CcSEcCtD
Fluorouracil—Diarrhoea—Topiramate—epilepsy syndrome	2.39e-05	0.000134	CcSEcCtD
Fluorouracil—Dizziness—Topiramate—epilepsy syndrome	2.31e-05	0.000129	CcSEcCtD
Fluorouracil—Vomiting—Topiramate—epilepsy syndrome	2.22e-05	0.000124	CcSEcCtD
Fluorouracil—Rash—Topiramate—epilepsy syndrome	2.2e-05	0.000123	CcSEcCtD
Fluorouracil—Dermatitis—Topiramate—epilepsy syndrome	2.2e-05	0.000123	CcSEcCtD
Fluorouracil—Headache—Topiramate—epilepsy syndrome	2.19e-05	0.000123	CcSEcCtD
Fluorouracil—Nausea—Topiramate—epilepsy syndrome	2.08e-05	0.000116	CcSEcCtD
Fluorouracil—ABCC5—Metabolism—APOE—epilepsy syndrome	3.87e-06	3.02e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ST3GAL3—epilepsy syndrome	3.86e-06	3.01e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CYP2C19—epilepsy syndrome	3.85e-06	3e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CYP11A1—epilepsy syndrome	3.82e-06	2.98e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—POMC—epilepsy syndrome	3.82e-06	2.98e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—KCNB1—epilepsy syndrome	3.81e-06	2.98e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PFKL—epilepsy syndrome	3.81e-06	2.98e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CACNA2D2—epilepsy syndrome	3.81e-06	2.98e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—SLCO1A2—epilepsy syndrome	3.81e-06	2.98e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—SLC6A8—epilepsy syndrome	3.81e-06	2.98e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ADSL—epilepsy syndrome	3.8e-06	2.97e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	3.8e-06	2.96e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GBE1—epilepsy syndrome	3.8e-06	2.96e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ADSL—epilepsy syndrome	3.78e-06	2.95e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	3.73e-06	2.91e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GLUL—epilepsy syndrome	3.73e-06	2.91e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—HMOX1—epilepsy syndrome	3.72e-06	2.9e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	3.71e-06	2.89e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GLUL—epilepsy syndrome	3.71e-06	2.89e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	3.71e-06	2.89e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—CAT—epilepsy syndrome	3.67e-06	2.87e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—MTOR—epilepsy syndrome	3.67e-06	2.86e-05	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—SRC—epilepsy syndrome	3.67e-06	2.86e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CACNA1D—epilepsy syndrome	3.66e-06	2.86e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CACNA1D—epilepsy syndrome	3.64e-06	2.84e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PTGS2—epilepsy syndrome	3.64e-06	2.84e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ABCG2—epilepsy syndrome	3.59e-06	2.8e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—ABCB1—epilepsy syndrome	3.57e-06	2.79e-05	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—VEGFA—epilepsy syndrome	3.57e-06	2.79e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	3.57e-06	2.78e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—FYN—epilepsy syndrome	3.56e-06	2.78e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—AGT—epilepsy syndrome	3.52e-06	2.75e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—FGF2—epilepsy syndrome	3.51e-06	2.74e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CYP2C19—epilepsy syndrome	3.5e-06	2.73e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—NEU1—epilepsy syndrome	3.49e-06	2.72e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ATIC—epilepsy syndrome	3.49e-06	2.72e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—UPB1—epilepsy syndrome	3.49e-06	2.72e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—ALB—epilepsy syndrome	3.48e-06	2.72e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CYP11A1—epilepsy syndrome	3.47e-06	2.71e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	3.47e-06	2.71e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CYP2D6—epilepsy syndrome	3.45e-06	2.69e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—APOE—epilepsy syndrome	3.45e-06	2.69e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—TXNRD1—epilepsy syndrome	3.42e-06	2.67e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—YWHAZ—epilepsy syndrome	3.42e-06	2.67e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—TXNRD1—epilepsy syndrome	3.4e-06	2.66e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—NT5E—epilepsy syndrome	3.38e-06	2.64e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ALAD—epilepsy syndrome	3.38e-06	2.64e-05	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	3.38e-06	2.64e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	3.36e-06	2.62e-05	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—AVP—epilepsy syndrome	3.35e-06	2.61e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—POMC—epilepsy syndrome	3.33e-06	2.59e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—AQP1—epilepsy syndrome	3.32e-06	2.59e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—GPX1—epilepsy syndrome	3.32e-06	2.59e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—AQP1—epilepsy syndrome	3.3e-06	2.58e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.29e-06	2.57e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—ADRA2A—epilepsy syndrome	3.28e-06	2.56e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—BCHE—epilepsy syndrome	3.27e-06	2.55e-05	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—AKT1—epilepsy syndrome	3.26e-06	2.54e-05	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—AKT1—epilepsy syndrome	3.26e-06	2.54e-05	CbGpPWpGaD
Fluorouracil—ALB—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	3.25e-06	2.53e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GBE1—epilepsy syndrome	3.24e-06	2.53e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	3.24e-06	2.53e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	3.23e-06	2.52e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	3.23e-06	2.52e-05	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	3.22e-06	2.51e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—MTOR—epilepsy syndrome	3.2e-06	2.49e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.19e-06	2.49e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.17e-06	2.48e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	3.17e-06	2.47e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PTGS2—epilepsy syndrome	3.17e-06	2.47e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	3.16e-06	2.46e-05	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	3.14e-06	2.45e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CYP2D6—epilepsy syndrome	3.13e-06	2.45e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—SLC2A1—epilepsy syndrome	3.12e-06	2.43e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ADSL—epilepsy syndrome	3.09e-06	2.41e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PLCB1—epilepsy syndrome	3.09e-06	2.41e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—TH—epilepsy syndrome	3.08e-06	2.4e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	3.05e-06	2.38e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PTGS2—epilepsy syndrome	3.05e-06	2.38e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PLAU—epilepsy syndrome	3.04e-06	2.37e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GLUL—epilepsy syndrome	3.03e-06	2.37e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—ALB—epilepsy syndrome	3.03e-06	2.37e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CHRM3—epilepsy syndrome	3.01e-06	2.34e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—KCNJ11—epilepsy syndrome	3.01e-06	2.34e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CHRM3—epilepsy syndrome	2.99e-06	2.33e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—KCNJ11—epilepsy syndrome	2.99e-06	2.33e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ADRA2A—epilepsy syndrome	2.98e-06	2.33e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	2.98e-06	2.32e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—BCHE—epilepsy syndrome	2.97e-06	2.32e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	2.97e-06	2.31e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—POMC—epilepsy syndrome	2.96e-06	2.31e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—SRC—epilepsy syndrome	2.94e-06	2.3e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—AGT—epilepsy syndrome	2.91e-06	2.27e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—NT5E—epilepsy syndrome	2.89e-06	2.26e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ALAD—epilepsy syndrome	2.89e-06	2.26e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—APOE—epilepsy syndrome	2.85e-06	2.23e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—SLC2A1—epilepsy syndrome	2.84e-06	2.21e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PRKCB—epilepsy syndrome	2.82e-06	2.2e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PLCB1—epilepsy syndrome	2.8e-06	2.19e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.8e-06	2.18e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—TH—epilepsy syndrome	2.79e-06	2.18e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—NOS2—epilepsy syndrome	2.79e-06	2.18e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	2.79e-06	2.17e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.78e-06	2.17e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	2.76e-06	2.15e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	2.76e-06	2.15e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.74e-06	2.14e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.73e-06	2.13e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—AQP1—epilepsy syndrome	2.7e-06	2.11e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—ALB—epilepsy syndrome	2.7e-06	2.11e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	2.7e-06	2.11e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PTGS2—epilepsy syndrome	2.65e-06	2.07e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ADSL—epilepsy syndrome	2.64e-06	2.06e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.6e-06	2.03e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GLUL—epilepsy syndrome	2.59e-06	2.02e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—HMOX1—epilepsy syndrome	2.57e-06	2e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—SRC—epilepsy syndrome	2.56e-06	2e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	2.55e-06	1.99e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CAT—epilepsy syndrome	2.53e-06	1.98e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—ABCB1—epilepsy syndrome	2.46e-06	1.92e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—POMC—epilepsy syndrome	2.45e-06	1.91e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	2.45e-06	1.91e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	2.45e-06	1.91e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	2.45e-06	1.91e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ABCG2—epilepsy syndrome	2.44e-06	1.9e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	2.39e-06	1.86e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	2.38e-06	1.86e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CYP2C19—epilepsy syndrome	2.37e-06	1.85e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	2.37e-06	1.85e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PTGS2—epilepsy syndrome	2.36e-06	1.84e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CYP11A1—epilepsy syndrome	2.36e-06	1.84e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.36e-06	1.84e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.34e-06	1.83e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—HMOX1—epilepsy syndrome	2.33e-06	1.82e-05	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—AKT1—epilepsy syndrome	2.32e-06	1.81e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—AQP1—epilepsy syndrome	2.31e-06	1.8e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CAT—epilepsy syndrome	2.3e-06	1.8e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—GPX1—epilepsy syndrome	2.29e-06	1.79e-05	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—AKT1—epilepsy syndrome	2.28e-06	1.78e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.28e-06	1.78e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ABCB1—epilepsy syndrome	2.24e-06	1.75e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—ALB—epilepsy syndrome	2.24e-06	1.74e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.23e-06	1.74e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	2.22e-06	1.73e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.15e-06	1.68e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	2.14e-06	1.67e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CYP2D6—epilepsy syndrome	2.13e-06	1.66e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	2.09e-06	1.63e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	2.09e-06	1.63e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—GPX1—epilepsy syndrome	2.08e-06	1.62e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	2.04e-06	1.59e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—BCHE—epilepsy syndrome	2.03e-06	1.58e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ADRA2A—epilepsy syndrome	2.03e-06	1.58e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—BCHE—epilepsy syndrome	2.02e-06	1.57e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—AGT—epilepsy syndrome	2.01e-06	1.57e-05	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	2e-06	1.56e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	1.99e-06	1.56e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—APOE—epilepsy syndrome	1.97e-06	1.54e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PTGS2—epilepsy syndrome	1.96e-06	1.53e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.95e-06	1.52e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	1.94e-06	1.52e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	1.94e-06	1.51e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	1.93e-06	1.51e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—SLC2A1—epilepsy syndrome	1.93e-06	1.5e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.92e-06	1.5e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	1.92e-06	1.49e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—TH—epilepsy syndrome	1.91e-06	1.49e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.91e-06	1.49e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PLCB1—epilepsy syndrome	1.9e-06	1.49e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—TH—epilepsy syndrome	1.9e-06	1.48e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.88e-06	1.47e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.87e-06	1.46e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—AKT1—epilepsy syndrome	1.83e-06	1.43e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—AGT—epilepsy syndrome	1.82e-06	1.42e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—APOE—epilepsy syndrome	1.79e-06	1.39e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.75e-06	1.36e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	1.74e-06	1.36e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	1.7e-06	1.33e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—POMC—epilepsy syndrome	1.69e-06	1.32e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	1.66e-06	1.3e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—SRC—epilepsy syndrome	1.66e-06	1.29e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	1.66e-06	1.29e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—BCHE—epilepsy syndrome	1.65e-06	1.29e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	1.65e-06	1.29e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.64e-06	1.28e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—VEGFA—epilepsy syndrome	1.62e-06	1.26e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	1.59e-06	1.24e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—AKT1—epilepsy syndrome	1.59e-06	1.24e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—HMOX1—epilepsy syndrome	1.58e-06	1.24e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	1.58e-06	1.23e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CAT—epilepsy syndrome	1.57e-06	1.23e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CAT—epilepsy syndrome	1.56e-06	1.22e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	1.56e-06	1.22e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—TH—epilepsy syndrome	1.55e-06	1.21e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—ALB—epilepsy syndrome	1.54e-06	1.2e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—POMC—epilepsy syndrome	1.54e-06	1.2e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—AKT1—epilepsy syndrome	1.53e-06	1.19e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.53e-06	1.19e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	1.53e-06	1.19e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—ABCB1—epilepsy syndrome	1.52e-06	1.19e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.49e-06	1.17e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	1.49e-06	1.16e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—GPX1—epilepsy syndrome	1.42e-06	1.11e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	1.42e-06	1.11e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—GPX1—epilepsy syndrome	1.41e-06	1.1e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—BCHE—epilepsy syndrome	1.41e-06	1.1e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—ALB—epilepsy syndrome	1.4e-06	1.09e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PTGS2—epilepsy syndrome	1.35e-06	1.05e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	1.35e-06	1.05e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—AKT1—epilepsy syndrome	1.33e-06	1.04e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	1.33e-06	1.04e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—TH—epilepsy syndrome	1.33e-06	1.04e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.31e-06	1.02e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	1.3e-06	1.01e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CAT—epilepsy syndrome	1.28e-06	9.98e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—AGT—epilepsy syndrome	1.25e-06	9.72e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	1.24e-06	9.71e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—AGT—epilepsy syndrome	1.24e-06	9.67e-06	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PTGS2—epilepsy syndrome	1.23e-06	9.56e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—APOE—epilepsy syndrome	1.22e-06	9.53e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—APOE—epilepsy syndrome	1.21e-06	9.47e-06	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—AKT1—epilepsy syndrome	1.19e-06	9.26e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—GPX1—epilepsy syndrome	1.16e-06	9.03e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	1.11e-06	8.64e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CAT—epilepsy syndrome	1.09e-06	8.53e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	1.06e-06	8.3e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—POMC—epilepsy syndrome	1.05e-06	8.19e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—POMC—epilepsy syndrome	1.04e-06	8.14e-06	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—AKT1—epilepsy syndrome	1.03e-06	8.05e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—AGT—epilepsy syndrome	1.01e-06	7.91e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—APOE—epilepsy syndrome	9.94e-07	7.75e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—GPX1—epilepsy syndrome	9.89e-07	7.71e-06	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—AKT1—epilepsy syndrome	9.83e-07	7.67e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—ALB—epilepsy syndrome	9.56e-07	7.46e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—AGT—epilepsy syndrome	8.67e-07	6.76e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—POMC—epilepsy syndrome	8.54e-07	6.66e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—APOE—epilepsy syndrome	8.49e-07	6.63e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	8.37e-07	6.53e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PTGS2—epilepsy syndrome	8.32e-07	6.49e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—ALB—epilepsy syndrome	7.78e-07	6.07e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—POMC—epilepsy syndrome	7.3e-07	5.69e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	6.81e-07	5.31e-06	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—AKT1—epilepsy syndrome	6.78e-07	5.29e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—ALB—epilepsy syndrome	6.65e-07	5.19e-06	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—AKT1—epilepsy syndrome	6.16e-07	4.8e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	5.82e-07	4.54e-06	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—AKT1—epilepsy syndrome	4.21e-07	3.28e-06	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—AKT1—epilepsy syndrome	4.18e-07	3.26e-06	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—AKT1—epilepsy syndrome	3.42e-07	2.67e-06	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—AKT1—epilepsy syndrome	2.92e-07	2.28e-06	CbGpPWpGaD
